{"slideshow_credits": null, "snippet": "In seeking to prevent a sale of the company on the cheap, Netflix tries to be noncontroversial. But its battle with the activist investor Carl Icahn is far from over.", "abstract": "In seeking to prevent a sale of the company on the cheap, Netflix tries to be noncontroversial. But its battle with the activist investor Carl Icahn is far from over.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Steven", "role": "reported", "rank": 1, "organization": ""}], "original": "By STEVEN M. DAVIDOFF"}, "web_url": "http://dealbook.nytimes.com/2012/11/06/netflixs-poison-pill-has-a-shareholder-friendly-flavor/", "lead_paragraph": null, "headline": {"main": "Netflix's Poison Pill Has a Shareholder-Friendly Flavor", "kicker": "DealBook"}, "_id": "509e551f00315214fbb790d1", "word_count": "1073", "multimedia": [], "pub_date": "2012-11-06T14:14:27Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "persons", "value": "Burkle, Ronald W", "rank": "1"}, {"name": "persons", "value": "Icahn, Carl C", "rank": "2"}, {"name": "organizations", "value": "Netflix Inc", "rank": "1"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "1"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}